ForeseeHome NRich Registry

Running, not enrolling

Conditions studied: Age-Related Macular Degeneration

In brief

This registry will compare functional and structural data of progression of Intermediate AMD (iAMD) and conversion to neovascular AMD (NV-AMD) while monitored at home with the ForeseeHome Monitoring System (FSH) and during routine care with Spectral Domain Optical Coherence Tomography (SD-OCT) and to validate the predictive value of a non-NV-AMD FSH alerts.

Key facts

Study ID

NCT05690880

Run by

Notal Vision Inc.

People needed

20000

Starts

2022-12-15

Expected to finish

2027-12-15

Last updated by the study team

2023-02-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participants include those actively monitoring on the FSH program which requires diagnosis of intermediate AMD and visual acuity of 20/60 or better that establish a valid baseline in at least one eye.

You may not qualify if…

• Patients that are unable to establish a baseline

Where it is running

• NJ Retina — Toms River, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.